Bloomberg Law June 11, 2020
Torrey McClary, Ranee Adipat, Ryan Colaianni

The health-care industry has been devastated by the Covid-19 pandemic, and post-pandemic deals, partnerships, and mergers are expected to rise. King & Spalding attorneys and a senior vice president at ReviveHealth say as health systems race to the altar to beat out competitors for M&A targets and other strategic relationships, it’s critical that they are thoughtful in structuring their deals, justifying the activity, and communicating the benefits.

The Covid-19 pandemic has devastated the health-care industry. In addition to the tragedies that the pandemic has brought, health systems have universally experienced severe and rapid deterioration of their bottom lines due to plummeting patient volumes, pausing of high margin elective surgical procedures, and increased expenses.

By some estimates,...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Health System / Hospital, Mergers & Acquisitions / JV, Provider, Trends
LabConnect Agrees to Acquire A4P Consulting
Evidence On Private Equity Suggests That Containing Costs And Improving Outcomes May Go Hand-In-Hand
Boehringer signs $1.3B deal with RNA biotech Ochre Bio to team up against MASH
Novant Health and CHS counter FTC bid to block hospital deal
Informatica says it's not for sale, following Salesforce's reported interest in $10 billion deal

Share This Article